Page 187 - Read Online

Borzio et al. Hepatoma Res 2019;5:15 I http://dx.doi.org/10.20517/2394-5079.2019.11 Page 15 of 16

39. Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, et al. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in
the diagnosis of hepatocellular carcinoma. Radiology 2010;255:459-66.
40. Grazioli L, Morana G, Caudana R, Benetti A, Portolani N, et al. Hepatocellular carcinoma: correlation between gadobenate
dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 2000;35:25-34.
41. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Ueda K, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of
hepatic tumors and pathologic appearance. Abdom Imaging 1998;23:309-13.
42. Manfredi R, Maresca G, Baron RL, Cotroneo AR, De Gaetano AM, et al. Delayed MR imaging of hepatocellular carcinoma enhanced
by gadobenate dimeglumine (Gd-BOPTA). J Magn Reson Imaging 1999;9:704-10.
43. Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, et al. Expression of OATP1B3 determines uptake of Gd-EOB-
DTPA in hepatocellular carcinoma. J Gastroenterol 2009;44:793-8.
44. Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents,
hepatobiliary agents, and ancillary imaging features. Radiology 2014;273:30-50.
45. Vilgrain V, Van Beers BE, Pastor CM. Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRI. J Hepatol
2016;64:708-16.
46. Bartolozzi C, Battaglia V, Bargellini I, Bozzi E, Campanini D, et al. Contrast-enhanced magnetic resonance imaging of 102 nodules in
cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging 2013;38:290-6.
47. Kogita S, Imai Y, Okada M, Kim T, Onishi H, et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular
carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 2010;20:2405-13.
48. Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, et al. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic
acid-enhanced and diffusion-weighted MR imaging patterns. Radiology 2012;264:761-70.
49. Kwon HJ, Byun JH, Kim JY, Hong GS, Won HJ, et al. Differentiation of small (≤ 2 cm) hepatocellular carcinomas from small benign
nodules in cirrhotic liver on gadoxetic acidenhanced and diffusion-weighted magnetic resonance images. Abdom Imaging 2015;40:64-75.
50. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, et al. MR imaging of intravoxel incoherent motions: application to
diffusion and perfusion in neurologic disorders.Radiology 1986;161:401-7.
51. Li YT, Cercueil JP, Yuan J, Chen W, Loffroy R, et al. Liver intravoxel incoherent motion (IVIM) magnetic resonance imaging: a
comprehensive review of published data on normal values and applications for fibrosis and tumor evaluation. Quant Imaging Med
Surg 2017;7:59-78.
52. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation
with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999;210:617-23.
53. Iima M, Le Bihan D. Clinical intravoxel incoherent motion and diffusion MR imaging: past, present, and future. Radiology
2016;278:13-32.
54. Kwee TC, Takahara T, Koh DM, Nievelstein RA, Luijten PR. Comparison and reproducibility of ADC measurements in breathhold,
respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reason Imaging 2008;28:1141-8.
55. Liau J, Lee J, Schroeder ME, Sirlin CB, Bydder M. Cardiac motion in diffusion weighted MRI of the liver: artifact and a method of
correction. J Magn Reason Imaging 2012;35:318-27.
56. Renzulli M, Biselli B, Brocchi S, Granito A, Vasuri F, et al. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma
and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 2018;67:1674-82.
57. ACR Radiology. Available from: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LIRADS/CT-MRI-LI-
RADS-v2017. [Last accessed on 26 Apr 2019]
58. Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassi MMS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma.
Hepatology 2018;67:358-80.
59. European Association For The Study Of The Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL
clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018;69:182-236.
60. Liu X, Jiang H, Chen J, Zhou Y, Huang Z, et al. Gadoxetic acid disodium enhanced magnetic resonance imaging outperformed
multidetector computed tomography in diagnosing small hepatocellular carcinoma: a meta-analysis. Liver Transpl 2017;23:1505-18.
61. Roberts LR, Sirlin CB, Zaiem F, Almasri J, Prokop LJ, et al. Imaging for the diagnosis of hepatocellular carcinoma: a systematic
review and meta-analysis. Hepatology 2018;67:401-21.
62. Maruyama H, Sekimoto T, Yokosuka O. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma:
evidence from a 10-year experience. J Gastroenterol 2016;51:421-33.
63. Takahashi M, Maruyama H, Shimada T, Kamezaki H, Sekimoto T, kanai F et al. Characterization of hepatic lesions (< 30 mm) with
liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. Eur J Radiol 2013;82:75-84.
64. ACR Radiology. Available from: https://www.arc.org/clinical-resources/Reporting-and-data-System/LI-RADS-v2014. [Last accessed
on 26 Apr 2019]
65. Darnell A, Forner A, Rimola J, Reig M, García-Criado A, et al. Liver imaging reporting and data system with mr imaging: evaluation
in nodules 20 mm or smaller detected in cirrhosis at screening US. Radiology:2015;275:698-707.
66. Ronot M, Fouque O, Esvan M, Lebigot J, Aube C, et al. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-
invasive diagnosis of HCC smaller than 3 cm. J Hepatol 2018;68:715-23.
67. van der Pol CB, Lim CS, Sirlin CB, McGrath TA, Salameh JP, et al. Accuracy of the liver imaging reporting and data system in
computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy-a systematic review.
Gastroenterology 2019;156:976-86.
68. ACR Radiology. Available from: https://www.arc.org/Clinical Resources/Reporting-and-Data-System/LI-RADSv2018. [Last accessed
on 26 Apr 2019]
69. ACR Radiology. Available from: https://www.arc.org/Reporting-and-Data-System/LI-RADS/CEUS-LI-RADS-v2017 [Last accessed